Design and Testing of Stimulation and Myoelectric Recording Modules in an Implanted Distributed Neuroprosthetic System.
Nathaniel Makowski, Alexandru Campean, Joris Lambrecht...
https://pubmed.ncbi.nlm.nih.gov/33729949/Actively Recruiting
Led by MetroHealth Medical Center · Updated on 2025-12-19
13
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the safety and effectiveness of the Networked Neuroprosthesis Device - Upper Extremity NP-UE in people living with cervical spinal cord injury SCI. This device aims to restore hand and arm function by activating nerves and muscles in the upper extremity, helping individuals with paralysis regain hand grasp and reaching abilities. The study focuses on those with injuries at the cervical level, where hand function restoration is a top priority and current options are limited. Participants will receive an implant of the Networked Neuroprosthesis Device, which is a configurable system that stimulates nerves and senses voluntary movement or muscle signals to enable hand grasp. After implantation, participants undergo functional training and assessments. The study includes follow-up evaluations at three, six, and twelve months post-implant to monitor changes in hand and arm function. During the study, participants will be assessed using several tests including the Grasp-Release Test, Grasp Dynamometer for force measurement, Canadian Occupational Performance Measure COPM, Activities of Daily Living ADL Abilities Test, and the Spinal Cord Independence Measure III SCIM-III. These assessments occur before implantation and at multiple points after to track progress. Researchers will also monitor safety and effectiveness throughout the trial, which lasts up to at least one year post-implant.
CONDITIONS
Grasp-Release Assessment of a Networked Neuroprosthesis Device
K
KIm Walsh, OTR/L
A
Anne Bryden, Ph.D, OTR/L
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
MetroHealth Medical Center
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Implantable Neuroprosthesis Device | Current Rehabilitation Therapy |
|---|---|---|
| Description | A surgically implanted, configurable neuromodulation system that activates paralyzed hand and forearm muscles to restore functional grasp and release, controlled via coordinated peripheral nerve stimulation. | A structured program of occupational and physical therapy using task-specific training, motor learning approaches, assistive devices, and sometimes surface electrical stimulation to improve upper limb function. |
| Role in Study | Evaluated as the sole intervention in this device-implantation study for adults with cervical spinal cord injury. | Serves as the usual care pathway for similar patients who do not receive an implanted neuroprosthesis. |
| Primary Use | Restoring ability to grasp and release objects in people with paralysis of the hand and forearm muscles due to cervical spinal cord injury. | Improving functional hand and arm use for daily activities in people with similar paralysis from cervical spinal cord injury. |
| How It Is Given or Performed | Surgical implantation of the device, followed by rehabilitation for device calibration, training users in coordinated grasp and release through electrical stimulation of selected muscles. | Therapy delivered through regular sessions with occupational and physical therapists. Some programs integrate surface electrical stimulation or assistive technology, depending on patient needs. |
| Evidence and Research Status | Currently under study; no published outcome results from this trial yet. Prior studies support feasibility and device development, but patient benefits in this population are not yet established. | Widely supported by clinical evidence and practice guidelines as the mainstay for improving upper limb function in people with cervical spinal cord injury, though individual response may vary. |
| Important Limitations | Requires surgical implantation, may not be suitable for all patients, and evidence for functional benefit is limited to small studies or pilot data. Long-term effects and safety remain under investigation. | Gains from standard therapy are often gradual and may plateau; full recovery of hand/arm function is uncommon, and some patients may continue to experience substantial limitations. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of implant plus immediate post-operative period
Participants receive an implant of the Networked Neuroprosthesis Device for arm and hand function.
1 implantation visit and immediate post-operative care
Duration - Up to 12 months post-implant
Participants undergo functional training and assessment with the implanted Networked Neuroprosthesis Device to restore hand and arm function.
Assessments at pre-implant, 3 months, 6 months, and 12 months post-implant
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nathaniel Makowski, Alexandru Campean, Joris Lambrecht...
https://pubmed.ncbi.nlm.nih.gov/33729949/Chester H Ho, Ronald J Triolo, Anastasia L Elias...
https://pubmed.ncbi.nlm.nih.gov/25064792/P Hunter Peckham, Kevin L Kilgore
https://pubmed.ncbi.nlm.nih.gov/23481680/MetroHealth Medical Center
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborating Sponsor